Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.43 Analyst target: $4.23 Upside: 894.12%
Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. The company is headquartered in Calgary, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.